NCT04613830

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Continuous Erector Spinae Plane Local Anesthetic Infusion for Postoperative Analgesia in Pediatric Patients Undergoing Nephrectomy: Randomized Controlled Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 2 Years – 7 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the analgesic efficacy of erector spinae plane block in pediatric cancer patients undergoing open nephrectomy

Detailed description

* Sixty patients will be included in this prospective randomized study. The patients will be allocated into two groups: the ESPB group (group E, n = 30) and the tramal group (group T, n =30). * All patients will receive standard general anesthesia. Ultrasound-guided ESPB will be performed to group erector spinae plane block

Conditions

• Pediatric Cancer

Interventions

Type	Name	Description
DRUG	Bupivacaine Hydrochloride	The patient will be placed in a sitting position under complete aseptic condition and a cover sheath will be used for the ultrasound probe with an appropriate amount of lubricating gel applied on the probe, a high-frequency linear ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the L3 spinous process. This should reveal three muscles superficial to the hyperechoic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae. then injecte bupivacaine hydrochloride
DRUG	Tramadol hydrochloride	Patients in group Tramadol will intravenously administrate dose of 1 mg/kg/8hr tramal to be increased upon patient needs up to 2mg/kg/6hr as rescue analgesic

Timeline

• Start date: 2020-11-20
• Primary completion: 2022-11-12
• Completion: 2022-12-01
• First posted: 2020-11-03
• Last updated: 2023-02-03

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study